ISRCTN ISRCTN49866681
DOI https://doi.org/10.1186/ISRCTN49866681
Secondary identifying numbers G9401611
Submission date
23/10/2000
Registration date
23/10/2000
Last edited
11/03/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Study website

Contact information

Dr Andrew J Molyneux
Scientific

Oxford Neurovascular & Neuroradiology Research Unit (ONNRU)
West Wing, Level 6
John Radcliffe Hospital
Headley Way
Oxford
OX3 9DU
United Kingdom

Phone +44 (0)1865 234755
Email andy.molyneux@nds.ox.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleInternational Subarachnoid Aneurysm Trial
Study acronymISAT
Study hypothesisTo compare the safety and efficacy of an endovascular treatment policy of ruptured intracranial aneurysms with a conventional neurosurgical treatment policy in an eligible population.

Primary objective: To determine whether an endovascular treatment policy of acutely ruptured intracranial aneurysms compared with a neurosurgical treatment policy, reduces the proportion of patients with a moderate or poor outcome (defined by Rankin grade 3-6 ) by 25% at one year.

Secondary objectives: To determine if:
1. This is as effective as neurosurgery in preventing re-bleeding from the treated aneurysm including long-term follow up
2. This results in a better quality of life than neurosurgery at one year (Euroquol measure)
3. This is more cost effective than neurosurgical treatment
4. This improves the neuropsychological outcome at one year (selected centres only)
Ethics approval(s)Not provided at time of registration
ConditionNeuroscience, psychiatry
Intervention1. Endovascular treatment policy of ruptured intracranial aneurysms
2. A conventional neurosurgical treatment policy
Intervention typeProcedure/Surgery
Primary outcome measureModified Ranking scale, Glasgow outcome scale, Neuropsychology assessment in some centres. Euroquol quality of life assessment, health economic evaluation including back to work rates
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1997
Overall study end date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants2143
Participant inclusion criteria1. Proven subarachnoid haemorrhage (SAH) on Computed Tomography (CT) or lumbar puncture
2. Presence of an intracranial aneurysm demonstrated by intra-arterial angiography likely to be responsible for the SAH
3. The patient in a clinical state that justifies treatment at some time by either surgical or endovascular means
4. Intracranial aneurysm judged to be suitable for either technique based on its angiographic anatomy and the responsible clinician is uncertain which is the best method of treatment
5. Appropriate consent of the patient or relatives
Participant exclusion criteria1. More than 28 days from SAH, unproven SAH
2. Unsuitable for both treatments
3. Refusal of consent
4. Patient participating in another trial
Recruitment start date01/01/1997
Recruitment end date31/12/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Oxford Neurovascular & Neuroradiology Research Unit (ONNRU)
Oxford
OX3 9DU
United Kingdom

Sponsor information

Oxford Radcliffe Hospital NHS Trust (UK)
Hospital/treatment centre

John Radcliffe Hospital
Headley Way
Oxford
OX3 9DU
England
United Kingdom

Website http://www.oxfordradcliffe.nhs.uk/home.aspx
ROR logo "ROR" https://ror.org/03h2bh287

Funders

Funder type

Research council

Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2005 Yes No
Results article results 01/08/2010 Yes No
Results article results 01/12/2011 Yes No
Results article results 21/02/2015 Yes No